Literature DB >> 34645607

ANGPTL4-Mediated Promotion of Glycolysis Facilitates the Colonization of Fusobacterium nucleatum in Colorectal Cancer.

Xin Zheng1,2, Rui Liu1, Chenchen Zhou1, Haopeng Yu3,4, Wanyi Luo1, Jianhui Zhu1,2, Jiaxin Liu1,2, Zhe Zhang5, Na Xie5, Xian Peng1, Xin Xu1,2, Lei Cheng1,2, Quan Yuan1, Canhua Huang6, Xuedong Zhou7,2.   

Abstract

Colorectal cancer is a severe health problem worldwide, and accumulating evidence supports the contribution of Fusobacterium nucleatum (F. nucleatum) to colorectal cancer development, metastasis, and chemoresistance. However, the mechanisms underlying the colonization of F. nucleatum in colorectal cancer tissue are not yet clarified. Here we demonstrate that F. nucleatum infection mediated elevation of angiopoietin-like 4 (ANGPTL4) expression. Upregulated ANGPTL4 promoted glucose uptake and glycolysis activity in colorectal cancer cells in vitro and in vivo, which are necessary for the colonization of F. nucleatum. Furthermore, overall increased acetylation of histone H3 lysine 27 was observed in F. nucleatum-infected colorectal cancer cells and patient tumors, which was responsible for the corresponding transcriptional upregulation of ANGPTL4. These data indicate that the metabolic reprogramming of cancer cells induced by F. nucleatum is essential for its enrichment and persistence in colorectal cancer, providing a novel potential target for the clinical intervention of F. nucleatum-related colorectal cancer. SIGNIFICANCE: F. nucleatum colonization in colorectal cancer is regulated by ANGPTL4-mediated glycolysis, suggesting that this axis could be targeted for combined repression of F. nucleatum and cancer progression. ©2021 The Authors; Published by the American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34645607     DOI: 10.1158/0008-5472.CAN-21-2273

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  6 in total

1.  Fusobacterium nucleatum promotes colon cancer progression by changing the mucosal microbiota and colon transcriptome in a mouse model.

Authors:  Na Wu; Yu-Qing Feng; Na Lyu; Di Wang; Wei-Dong Yu; Yong-Fei Hu
Journal:  World J Gastroenterol       Date:  2022-05-14       Impact factor: 5.374

2.  Alterations of lung microbiota in patients with non-small cell lung cancer.

Authors:  Wen Zeng; ChengZhu Zhao; Mengge Yu; Hailong Chen; Yiyun Pan; Yuhuan Wang; Hejing Bao; Hao Ma; Shudong Ma
Journal:  Bioengineered       Date:  2022-03       Impact factor: 3.269

3.  Development and Validation of a Novel Hypoxia Score for Predicting Prognosis and Immune Microenvironment in Rectal Cancer.

Authors:  Kaiyan Yang; Zhaolong Shen; Ning Yin; Jun Quan; Mengwen Wang; Kai Gao
Journal:  Front Surg       Date:  2022-04-25

Review 4.  Fusobacterium nucleatum and Malignant Tumors of the Digestive Tract: A Mechanistic Overview.

Authors:  Yue Lai; Jun Mi; Qiang Feng
Journal:  Bioengineering (Basel)       Date:  2022-06-28

5.  NXPH4 Promotes Gemcitabine Resistance in Bladder Cancer by Enhancing Reactive Oxygen Species and Glycolysis Activation through Modulating NDUFA4L2.

Authors:  Decai Wang; Pu Zhang; Zijian Liu; Yifei Xing'; Yajun Xiao
Journal:  Cancers (Basel)       Date:  2022-08-03       Impact factor: 6.575

6.  Identification of a novel lipid metabolism-related gene signature for predicting colorectal cancer survival.

Authors:  Yanpeng Huang; Jinming Zhou; Haibin Zhong; Ning Xie; Fei-Ran Zhang; Zhanmin Zhang
Journal:  Front Genet       Date:  2022-09-06       Impact factor: 4.772

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.